PDGFRB and neoplasm: This combined therapy, significantly delayed the initial onset of tumor growth for both phenotypes (Figure 9B), but resulted in the emergence of newer phenotypes as evident from the presence of unique/unfamiliar populations of MAP2+ and PDGFRβ+ cells (Figure 10E).